- Home
- ULS vs ICLR Comparison
ULS vs ICLR Comparison
Compare ULS & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ULS | ICLR |
|---|---|---|
| Founded | 1894 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.6B | 13.1B |
| IPO Year | 2023 | 2001 |
Fundamental Metrics
Financial Performance| Metric | ULS | ICLR |
|---|---|---|
| Price | $66.91 | $161.65 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 18 |
| Target Price | $96.48 | ★ $185.82 |
| AVG Volume (30 Days) | 698.1K | ★ 967.5K |
| Earning Date | 11-03-2026 | 10-21-2026 |
| Dividend Yield | ★ 0.88% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.66 | N/A |
| Revenue | ★ $3,053,000,000.00 | N/A |
| Revenue This Year | $5.25 | N/A |
| Revenue Next Year | $7.23 | $3.69 |
| P/E Ratio | $38.39 | ★ $12.91 |
| Revenue Growth | ★ 6.38 | N/A |
| 52 Week Low | $63.17 | $66.57 |
| 52 Week High | $107.54 | $203.91 |
Technical Indicators
Market Signals| Indicator | ULS | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 34.89 | 49.06 |
| Support Level | $63.17 | $162.32 |
| Resistance Level | $73.62 | $180.07 |
| Average True Range (ATR) | 1.92 | 6.07 |
| MACD | 0.38 | 0.05 |
| Stochastic Oscillator | 32.36 | 33.62 |
Price Performance
Historical ComparisonAbout ULS UL Solutions Inc.
UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.
About ICLR ICON plc
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.